Reactogenicity and safety of a liquid human rotavirus vaccine (RIX4414) in healthy adults, children and infants in China: Randomized, double-blind, placebo-controlled Phase I studies

We report the findings of three randomized, double-blind, placebo-controlled Phase I studies undertaken to support licensure of the liquid formulation of the human G1P[8] rotavirus (RV) vaccine (RIX4414; GlaxoSmithKline Biologicals SA) in China. Healthy adults aged 18–45 y (n = 48) and children aged...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Rong-Cheng, Li, Yan-Ping, Mo, Zhao-Jun, Luo, Dong, Huang, Teng, Kong, Ji-Lian, Wang, Lao-Hong, Song, Ning-Sheng, Liu, Aixue, Zhang, Helen, Liao, Xueyan, Karkada, Naveen, Han, Htay Htay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906260/
https://www.ncbi.nlm.nih.gov/pubmed/23807360
http://dx.doi.org/10.4161/hv.25076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906260/
https://www.ncbi.nlm.nih.gov/pubmed/23807360
http://dx.doi.org/10.4161/hv.25076

Ejemplares similares